KVUE

8-K - Kenvue Inc. (0001944048) (Filer)

DALLAS, Oct. 13, 2026 /PRNewswire/ -- Kimberly-Clark Corporation (NASDAQ:KMB) ("Kimberly-Clark") announced today that the requisite number of consents have been received to adopt certain proposed amendments (the "Amendments") with respect to all outstanding notes of Kenvue Inc. (NYSE:KVUE) ("Kenvue"). The results are based on (i) early tenders in the offers to exchange (each an "Exchange Offer" and, collectively, the "Exchange Offers") any and all outstanding notes (the "Kenvue Notes") issued by Kenvue for up to $7,000,000,000 aggregate principal amount of new notes to be issued by Kimberly-Clark (the "Kimberly-Clark Notes") and cash and (ii) related consent solicitations (each, a "Consent S

4 - Kenvue Inc. (0001944048) (Issuer)

4 - Kenvue Inc. (0001944048) (Issuer)

4 - Kenvue Inc. (0001944048) (Issuer)

4 - Kenvue Inc. (0001944048) (Issuer)

4 - Kenvue Inc. (0001944048) (Issuer)

4 - Kenvue Inc. (0001944048) (Issuer)

Russ Torres to Depart Kimberly-Clark for External CEO RoleCarlos De Jesus to be Appointed as President, North America and Leonardo Curado to be Appointed as President, EMEA After Kenvue AcquisitionDALLAS, Oct. 1, 2026 /PRNewswire/ -- Kimberly-Clark Corporation (NASDAQ:KMB) today announced planned executive transitions and updates to the future leadership team for the company upon completion of its pending acquisition of Kenvue Inc. (NYSE:KVUE), which is expected in the fourth quarter of 2026.Russ Torres, President and Chief Operating Officer of Kimberly-Clark, and Head of the Integration Management Office (IMO), will leave the company to assume an external CEO role. He will remain with the c

Global research shows oral disease case numbers rose more than 3% over four years, as researchers warn that progress is too slow to meet the WHO’s 2030 target. This World Smile Day, LISTERINE® is launching Oral Care Counts – a multiyear education and advocacy initiative showing why oral health is an essential part of overall health and how practical daily habits, including a three-step oral care routine of brushing, flossing and rinsing, can support better oral health. Nearly half the world’s population is affected by oral disease – and the number of cases is rising. This World Smile Day, LISTERINE® is launching Oral Care Counts – a multiyear education and advocacy initiative showing

Research shared at the 35th European Academy of Dermatology and Venereology (EADV) Congress highlights the benefits of multifunctional sunscreens, colloidal oat formulations addressing acne, hyperpigmentation, eczema, UV-related skin damage, and the impact of 5% minoxidil for alopecia. Neutrogena®, Aveeno®, and Regaine®* will present 12 new scientific data sets at the 35th European Academy of Dermatology and Venereology (EADV) Congress taking place September 30th through October 3rd in Vienna. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260930489298/en/New Neutrogena science showcased at EADV 2026 in Vienna, Austria Abstrac

4 - Kenvue Inc. (0001944048) (Issuer)

4 - Kenvue Inc. (0001944048) (Issuer)

4 - Kenvue Inc. (0001944048) (Issuer)

DALLAS, Sept. 28, 2026 /PRNewswire/ -- Kimberly-Clark Corporation (NASDAQ:KMB) ("Kimberly-Clark") announced today the commencement, in connection with its previously announced pending acquisition ("Acquisition") of Kenvue Inc. (NYSE:KVUE) ("Kenvue"), of an exchange offer (each an "Exchange Offer" and, collectively, the "Exchange Offers") for any and all outstanding notes (the "Kenvue Notes") issued by Kenvue for up to $7,000,000,000 aggregate principal amount of new notes to be issued by Kimberly-Clark (the "Kimberly-Clark Notes") and cash. The following table sets forth the Exchange Consideration, Early Participation Premium,

Kenvue Inc. (NYSE:KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.21 per share on its common stock. The quarterly dividend is payable on October 2, 2026, to shareholders of record as of the close of business on September 21, 2026. About Kenvue Kenvue Inc. is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson’s®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we realize the extraordinary power of everyday care. Our teams work every day to put that pow

Accomplished legal executive and global litigator brings proven track record of enterprise risk management and strategic leadership to support Kimberly-Clark's next chapter of growthDALLAS, Aug. 13, 2026 /PRNewswire/ -- Kimberly-Clark Corporation (NASDAQ:KMB) today announced the appointment of Suzana Blades as Senior Vice President and General Counsel, effective September 1, 2026. She will report to Jeff Melucci, Chief Strategy, Business Development and Administrative Officer, and will become a member of Kimberly-Clark's Executive Leadership Team. Blades has also been named to the leadership team that will take effect upon comp

SCHEDULE 13G/A - Kenvue Inc. (0001944048) (Subject)

10-Q - Kenvue Inc. (0001944048) (Filer)

8-K - Kenvue Inc. (0001944048) (Filer)

Delivered Third Consecutive Quarter of Net and Organic Sales1 Growth Net Sales Increased 3.0%; Organic Sales Increased 1.6% Diluted EPS Increased 9% to $0.24; Adjusted Diluted EPS1 Increased 7% to $0.31 Results Met or Exceeded the Company’s Plans Across Key Metrics Kenvue Inc. (NYSE:KVUE) today announced financial results for the fiscal second quarter ended June 28, 2026. "We delivered our third consecutive quarter of net and organic sales growth, with broad-based gains across every segment and region," said Kirk Perry, Chief Executive Officer. "We also continued to drive operational efficiencies and increase strategic investment to fuel sustained momentum. Amidst a dynam

4 - Kenvue Inc. (0001944048) (Issuer)

Kenvue Inc. (NYSE:KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.21 per share on its common stock, which represents a 1.2 percent increase compared to the prior quarterly dividend. The quarterly dividend is payable on August 26, 2026, to shareholders of record as of the close of business on August 12, 2026. About Kenvue Kenvue Inc. is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson’s®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we realize the e

Kenvue Inc. (NYSE:KVUE) will announce its second quarter 2026 financial results before the market opens on August 6, 2026. Due to the pending transaction with Kimberly-Clark, Kenvue will not be hosting a quarterly conference call to review its financial results. The press release will be available on the company’s website at investors.kenvue.com. About Kenvue Kenvue Inc. is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson’s®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we realize th

4 - Kenvue Inc. (0001944048) (Issuer)